Oramed Pharmaceuticals (ORMP) Current Taxes (2022 - 2026)

Oramed Pharmaceuticals has reported Current Taxes for 5 years, with the latest figure at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Taxes rose 22.49% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $4.6 million (up 22.49% YoY), and the FY2025 full-year result was $3.3 million, up 2.56% from the prior year.
• Current Taxes for Q1 2026 stood at $4.6 million, up from $3.3 million in the prior quarter.
• The five-year high for Current Taxes was $4.6 million in Q1 2026, with the low at $11000.0 in Q4 2022.
• Historically, Current Taxes has averaged $1.7 million across 5 years, with a median of $344000.0 in 2025.
• Annual changes were most pronounced in 2023 — Current Taxes changed 0.0% — and 2025, when it surged 34336.36%.
• Oramed Pharmaceuticals' Current Taxes stood at $11000.0 in 2022, then changed by 0.0% to $11000.0 in 2023, then soared by 29027.27% to $3.2 million in 2024, then advanced by 2.56% to $3.3 million in 2025, then jumped by 41.21% to $4.6 million in 2026.
• The last three Current Taxes figures came in at $4.6 million (Q1 2026), $3.3 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.